Alkem Laboratories Limited
ALKEM
Kedudukan dalam Saham
#2796
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Harga Saham
$52.11
Modal Pasaran
$6.23B
Perubahan (1 hari)
-5.58%
Perubahan (1 tahun)
-17.32%
Negara
IN
Perdagangan Alkem Laboratories Limited (ALKEM)
Kategori
Healthcare
Hasil untuk Alkem Laboratories Limited (ALKEM)
Hasil pada Jun 2026 TTM: $1.66B
Menurut laporan kewangan terkini daripada Alkem Laboratories Limited, hasil semasa syarikat (TTM) ialah $1.66B. Pada tahun 2024, syarikat memperoleh hasil sebanyak $1.51B peningkatan berbanding hasil pada tahun 2023 iaitu $1.41B. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Alkem Laboratories Limited dari 2010 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2026 (TTM) | $1.66B | 9.80% |
| 2025 | $1.52B | 0.58% |
| 2024 | $1.51B | 6.78% |
| 2023 | $1.41B | 0.75% |
| 2022 | $1.40B | 16.24% |
| 2021 | $1.21B | 10.84% |
| 2020 | $1.09B | 3.92% |
| 2019 | $1.05B | 7.90% |
| 2018 | $969.78M | 11.98% |
| 2017 | $866.05M | 17.92% |
| 2016 | $734.41M | 23.43% |
| 2015 | $595.01M | 15.94% |
| 2014 | $513.19M | 20.29% |
| 2013 | $426.63M | 10.75% |
| 2012 | $385.23M | 3.89% |
| 2011 | $370.79M | 23.92% |
| 2010 | $299.23M | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| - | - |
CN
|
